Lie Zheng

Zhejiang Chinese Medical University — China

Medicine · Health Sciences

23h-index2.1kcitations95works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(24), Head and Neck Cancer Studies(18), Lung Cancer Diagnosis and Treatment(15), Cholangiocarcinoma and Gallbladder Cancer Studies(15), Radiomics and Machine Learning in Medical Imaging(13)

Publications95 total

Quantitative Multi-Parameter MRI Evaluation of Hashimoto\'s Thyroiditis Changes After Dietary Interventions
Medical Science Monitor·2025· 1 citedOpen Access
Comparison of efficacy and safety of lenvatinib vs. apatinib in combination with hepatic arterial infusion chemotherapy and immune checkpoint inhibitors for unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective study.
Journal of Clinical Oncology·2025
Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma: A multicenter real-world study.
Journal of Clinical Oncology·2025
Magnetic Resonance Imaging and [ <scp>18F</scp> ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract <scp>NK</scp> /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study
Head & Neck·2025Open Access
Comparison of efficacy and safety of PD-1 and PD-L1 antibodies in combination with hepatic arterial infusion chemotherapy and target therapy for unresectable intrahepatic cholangiocarcinoma: A multicenter retrospective study.
Journal of Clinical Oncology·2025· 2 cited
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma
Frontiers in Immunology·2024· 2 citedOpen Access
Colorimetric aptasensor based on temporally controllable light-stimulated oxidase-mimicking fluorescein for the sensitive detection of exosomes in mild conditions
Analytical Methods·2024· 3 cited
Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy
Journal of Inflammation Research·2023· 24 citedOpen Access
[Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
PubMed·2023· 2 cited
MicroRNA-211 Regulates Proliferation, Expansion, and Immune Inhibitory Function of Myeloid-Derived Suppressor Cells via Mediation of CHOP Expression
Immunological Investigations·2023· 5 citedOpen Access
Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trial.
Journal of Clinical Oncology·2023· 11 cited
AND-Gated Nanosensor for Imaging of Glutathione and Apyrimidinic Endonuclease 1 in Cells, Animals, and Organoids
ACS Applied Materials & Interfaces·2023· 13 cited
Machine Learning Generation of Dynamic Protein Conformational Ensembles
Molecules·2023· 28 citedOpen Access
Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: A prospective exploratory clinical trial
Lung Cancer·2023· 10 citedOpen Access
[The introduction of meningiomas in 2021 WHO classification of tumors of the central nervous system (5th edition)].
PubMed·2023· 1 cited
Comparison of anti–PD-L1 with anti–PD-1 antibodies in the combination of HAIC and lenvatinib for the treatment of unresectable hepatocellular carcinoma.
Journal of Clinical Oncology·2023· 3 cited
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
Journal of Clinical Oncology·2022· 151 citedOpen Access
A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma
Frontiers in Genetics·2022· 2 citedOpen Access
Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study
Frontiers in Immunology·2022· 20 citedOpen Access
Body mass index, as a novel predictor of hepatocellular carcinoma patients treated with Anti-PD-1 immunotherapy
Frontiers in Medicine·2022· 8 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Rong Guo(11), Shaohua Li(9), Jie Mei(8), Ming Shi(7), Lianghe Lu(7), Wei Wei(6), Peihong Wu(5), Yihong Ling(5), Mei Lan(5), Fei Han(5), Li Xu(4), Minshan Chen(4), Qiaoxuan Wang(4), Jingwen Zou(4), Wenping Lin(4), Yuhua Wen(4), Zhixing Guo(4), Yunxian Mo(4), Ning Lyu(3), Luwen Mu(3)